AirSculpt Technologies, Inc. (AIRS)
USD 5.85
(-7.0%)
USD 5.85
(-7.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 28.31 Million USD | 516.15% |
| 2022 | 3.51 Million USD | -80.06% |
| 2021 | 23.04 Million USD | 47.04% |
| 2020 | 15.67 Million USD | 178.75% |
| 2019 | 5.62 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 2.09 Million USD | -115.16% |
| 2024 Q1 | 13.82 Million USD | 230.83% |
| 2023 Q2 | 7.85 Million USD | 100.77% |
| 2023 Q1 | 3.91 Million USD | 235.95% |
| 2023 FY | - USD | 516.15% |
| 2023 Q4 | 5.45 Million USD | 51.95% |
| 2023 Q3 | 3.58 Million USD | -54.34% |
| 2022 Q1 | 715 Thousand USD | 106.93% |
| 2022 Q3 | 607 Thousand USD | -90.13% |
| 2022 Q2 | 6.15 Million USD | 760.42% |
| 2022 FY | - USD | -80.06% |
| 2022 Q4 | -2.87 Million USD | -574.3% |
| 2021 Q2 | 13.41 Million USD | 54.2% |
| 2021 FY | - USD | 47.04% |
| 2021 Q4 | -10.32 Million USD | -191.68% |
| 2021 Q3 | 11.26 Million USD | -16.04% |
| 2021 Q1 | 8.69 Million USD | 12.64% |
| 2020 Q4 | 7.72 Million USD | 58.24% |
| 2020 Q3 | 4.88 Million USD | 217.71% |
| 2020 Q2 | 1.53 Million USD | 0.0% |
| 2020 Q1 | 1.53 Million USD | 0.0% |
| 2020 FY | - USD | 178.75% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | 85.029% |
| Addus HomeCare Corporation | 106.55 Million USD | 73.43% |
| Amedisys, Inc. | 216.91 Million USD | 86.948% |
| American Oncology Network, Inc. | -39.35 Million USD | 171.947% |
| Astrana Health, Inc. | 123.68 Million USD | 77.11% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 36.159% |
| IMAC Holdings, Inc. | -5.94 Million USD | 576.088% |
| biote Corp. | 9.23 Million USD | -206.606% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 371.779% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | 78.11% |
| COMPASS Pathways plc | -123.8 Million USD | 122.869% |
| DocGo Inc. | 32.72 Million USD | 13.486% |
| The Ensign Group, Inc. | 353.23 Million USD | 91.985% |
| Healthcare Services Group, Inc. | 75.21 Million USD | 62.357% |
| InnovAge Holding Corp. | 1.15 Million USD | -2353.38% |
| Assure Holdings Corp. | -19.82 Million USD | 242.817% |
| The Joint Corp. | 9.14 Million USD | -209.701% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 126.983% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 282.016% |
| ModivCare Inc. | -26.75 Million USD | 205.839% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -7267.065% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 584.048% |
| Option Care Health, Inc. | 376.79 Million USD | 92.486% |
| P3 Health Partners Inc. | -81.07 Million USD | 134.922% |
| P3 Health Partners Inc. | -81.07 Million USD | 134.922% |
| The Pennant Group, Inc. | 30.36 Million USD | 6.773% |
| Surgery Partners, Inc. | 446.1 Million USD | 93.653% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 1098.348% |
| Talkspace, Inc. | -22.01 Million USD | 228.615% |
| Talkspace, Inc. | -22.01 Million USD | 228.615% |
| The Oncology Institute, Inc. | -70.45 Million USD | 140.185% |
| The Oncology Institute, Inc. | -70.45 Million USD | 140.185% |